STMicroelectronics stock price target lowered to €20 at Barclays

Barclays has lowered its price target for STMicroelectronics NV (NYSE:STM) to €20 from €22, while maintaining an Underweight rating, citing concerns over semiconductor industry recovery uncertainties, potential Section 232 risks, and overly optimistic gross margin expectations. The firm's revised target uses a lower 15x 2026 estimated P/E, suggesting the stock is currently overvalued at 19x 2026 estimated P/E, implying over 10% downside potential from current levels based on Barclays' analysis.

Analysis

Barclays has lowered its price target on STMicroelectronics NV (STM) to €20 from €22, maintaining an Underweight rating on the stock. The revision is driven by concerns over the uncertain trajectory of the semiconductor industry's recovery, potential Section 232 trade risks, and a belief that consensus gross margin expectations for the company are overly optimistic. The bank's valuation methodology has shifted to a more conservative 15x price-to-earnings multiple on 2026 estimates, down from 16x previously and aligning more closely with STM's historical average. This new target implies significant overvaluation at current levels, as Barclays notes STM presently trades at approximately 19x its 2026 estimated P/E, suggesting a potential downside of over 10%. The analysis is further compounded by longer-term geopolitical concerns related to China's role in the semiconductor landscape.

Key Decisions for Investors

• Investors with long positions in STM should re-evaluate their thesis, specifically the stock's current valuation premium and the underlying assumptions for gross margin expansion.
• The note from Barclays provides a clear bearish framework, suggesting potential opportunities for short-sellers or for implementing hedging strategies focused on geopolitical trade risks and a potential cyclical downturn in the semiconductor sector.
• It is critical to monitor STM's upcoming earnings reports for any guidance on gross margins and the shape of the industry recovery, as these are the key points of contention in Barclays' negative outlook.